See How the Major Players Keep Dominating the Global Transfection Reagents and Equipment Market

By -

This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.

(EMAILWIRE.COM, September 24, 2018 ) Browse 134 market data tables and 43 figures spread through 209 pages and in-depth TOC on “Transfection Reagents and Equipment Market”
https://www.marketsandmarkets.com/Market-Reports/transfection-reagents-equipment-market-139141146.html
Early buyers will receive 10% customization on this report.

Different Strategies Adopted by Major Leaders:

The key players in this market are continuously striving to gain larger shares and expand their existing product portfolios by agreements, collaborations, and partnerships.

The overall market was dominated by Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). Other players include Polyplus-transfection SA (France), Bio-Rad Laboratories Inc. (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte, Inc. (U.S.).

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=139141146

Global Market Dynamics:

Global Growth Drivers:

# Technological Advancements in Transfection Technology
# Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
# Increase in R&D Spending and Research Activities By Pharmaceutical and Biotech Companies
# Growing Research Activities in Cell Science
# Increase in Demand for Synthetic Genes
# Rising Incidence of Cancer Worldwide

Global Growth Restraints:

# Selective Effectiveness of Transfection Reagents
# Home Brew Reagents Restrict Sale of Commercial Kits
# High Cost of Transfection Reagents

Opportunities:

# Large-Scale Transfections
# High-Growth Opportunities in Asian Market

North America is expected to account for the largest share of the transfection reagents market, followed by Europe and Asia-Pacific. The largest share can be attributed to the increase in bio-based drug research, increase in demand for protein therapeutics, and increasing investment for development of biologics in the country. The Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

Some of the prominent players in the transfection reagents market include Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands). Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).

Target Audience:

# Biopharmaceutical companies
# Biotechnology companies
# Transfection equipment, reagent, and kit manufacturing companies
# Suppliers and distributors of transfection reagents
# Research institutes
# Academic centers
# Venture capitalists

Biotechnology Market Research Reports & Consulting@
https://www.marketsandmarkets.com/biotech-market-research-5.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Research Insight:
https://www.marketsandmarkets.com/ResearchInsight/transfection-reagents-equipment-market.asp

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more